127 related articles for article (PubMed ID: 21226767)
41. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
[TBL] [Abstract][Full Text] [Related]
42. Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Uro-oncology Society.
Eskicorapci SY; Türkeri L; Karabulut E; Cal C; Akpinar H; Baltaci S; Baykal K; ; Kattan MW; Ozen H
Urology; 2009 Dec; 74(6):1289-95. PubMed ID: 19589584
[TBL] [Abstract][Full Text] [Related]
43. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
44. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.
Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T
Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163
[TBL] [Abstract][Full Text] [Related]
45. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
[TBL] [Abstract][Full Text] [Related]
46. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma.
An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J
Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847
[TBL] [Abstract][Full Text] [Related]
47. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
[TBL] [Abstract][Full Text] [Related]
48. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
[TBL] [Abstract][Full Text] [Related]
49. Nomogram for 5-year relapse-free survival of a patient with advanced gastric cancer after surgery.
Muneoka Y; Akazawa K; Ishikawa T; Ichikawa H; Nashimoto A; Yabusaki H; Tanaka N; Kosugi SI; Wakai T
Int J Surg; 2016 Nov; 35():153-159. PubMed ID: 27664559
[TBL] [Abstract][Full Text] [Related]
50. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
[TBL] [Abstract][Full Text] [Related]
51. A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
Graefen M; Karakiewicz PI; Cagiannos I; Hammerer PG; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Huland H; Scardino PT; Kattan MW
Urol Oncol; 2002; 7(4):141-6. PubMed ID: 12474529
[TBL] [Abstract][Full Text] [Related]
52. Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~.
Tsutsumi T; Komura K; Hashimoto T; Muraoka R; Satake N; Matsunaga T; Tsujino T; Yoshikawa Y; Takai T; Minami K; Taniguchi K; Tanaka T; Uehara H; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Ohno Y; Azuma H
BMC Cancer; 2021 Feb; 21(1):201. PubMed ID: 33639880
[TBL] [Abstract][Full Text] [Related]
53. [Predicting postoperative recurrence of stage Ⅰ-Ⅲ renal clear cell carcinoma based on preoperative CT radiomics feature nomogram].
Zhang H; Yin F; Chen M; Qi A; Yang L; Cui W; Yang S; Wen G
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(9):1358-1365. PubMed ID: 34658350
[TBL] [Abstract][Full Text] [Related]
54. Comprehensive long-term assessment of outcomes following robot-assisted partial nephrectomy for renal cell carcinoma: the ROMe's achievement and its predicting nomogram.
Brassetti A; Anceschi U; Bertolo R; Ferriero M; Tuderti G; Costantini M; Capitanio U; Larcher A; Antonelli A; Mottrie A; Minervini A; Dell'oglio P; Veccia A; Amparore D; Flammia RS; Lombardo R; De Nunzio C; Benecchi L; Mari A; Porpiglia F; Montorsi F; Kaouk J; Autorino R; Gallucci M; Simone G
Minerva Urol Nefrol; 2020 Aug; 72(4):482-489. PubMed ID: 32298069
[TBL] [Abstract][Full Text] [Related]
55. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
[TBL] [Abstract][Full Text] [Related]
56. External validation of the RENAL nephrometry score nomogram for predicting high-grade renal cell carcinoma in solid, enhancing, and small renal masses.
Koo KC; Yoo H; Shin TY; Kim J; Choi YD; Rha KH; Ham WS
World J Urol; 2014 Feb; 32(1):249-55. PubMed ID: 24013182
[TBL] [Abstract][Full Text] [Related]
57. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
[TBL] [Abstract][Full Text] [Related]
58. Validation and comparison of the two Kattan nomograms in patients with prostate cancer treated with (125) iodine brachytherapy.
Kaplan A; German L; Chen J; Matzkin H; Mabjeesh NJ
BJU Int; 2012 Jun; 109(11):1661-5. PubMed ID: 22115188
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
[TBL] [Abstract][Full Text] [Related]
60. Predictive factors for late recurrence in patients with stage T1 clear cell renal cell carcinoma: a multiinstitutional study.
Ha YS; Park YH; Kang SH; Hong SH; Hwang TK; Byun SS; Kim YJ
Clin Genitourin Cancer; 2013 Mar; 11(1):51-5. PubMed ID: 23017336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]